Product
AM-101
2 clinical trials
1 indication
Indication
TinnitusClinical trial
Efficacy and Safety of AM-101 in the Treatment of Acute Peripheral Tinnitus 3Status: Completed, Estimated PCD: 2017-12-28
Clinical trial
AM-101 in the Post-Acute Treatment of Peripheral Tinnitus 2 (AMPACT2) - an Open-Label Extension to the TACTT3 StudyStatus: Completed, Estimated PCD: 2016-12-01